Parinda Mehta is an Oncology physician affiliated with Cincinnati Children's Hospital Medical Center. OpenAlex indexes 228 publications with 4,056 citations (h-index 36); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3333 Burnet Ave
Ml 11009
Cincinnati, OH 452293039
Telephone
513-636-0278Registry record last updated 8 Jul 2007.
Clinical trials
- Quercetin Dyskeratosis Congenita (DC)/Telomere Biology Disorders (TBD)
Sponsor: Children's Hospital Medical Center, Cincinnati
- Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation
Sponsor: Children's Hospital Medical Center, Cincinnati
- Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia
Sponsor: Children's Hospital Medical Center, Cincinnati
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
3 NIH research awards on record, funded 2013–2026 per NIH RePORTER. The latest:
- Precision Alemtuzumab Therapy in Allogeneic HCT
Cincinnati Childrens Hosp Med Ctr
FY2026$323,252R01HD107690 - Precision Alemtuzumab Therapy in Allogeneic HCT
Cincinnati Childrens Hosp Med Ctr
FY2025$361,487R01HD107690 - Precision Alemtuzumab Therapy in Allogeneic HCT
Cincinnati Childrens Hosp Med Ctr
FY2024$329,539R01HD107690
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis
Biology of Blood and Marrow Transplantation
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Andrea Beaton, MD
Cincinnati Children's Hospital Medical Center
Prasad Devarajan, MD
Cincinnati Children's Hospital Medical Center
Stuart Goldstein, MD
Cincinnati Children's Hospital Medical Center
Tracy Glauser, MD
Cincinnati Children's Hospital Medical Center
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”